The global market for Bone Morphogenetic Proteins is estimated at US$545.3 Million in 2023 and is projected to reach US$643 Million by 2030, growing at a CAGR of 2.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Bone Morphogenetic Proteins Market]( "Bone Morphogenetic Proteins Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2) segment, which is expected to reach US$437.1 Million by 2030 with a CAGR of 2.6%. The Recombinant Human Bone Morphogenetic Protein-7 (rhBMP-7) segment is also set to grow at 2% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $163.6 Million in 2023, and China, forecasted to grow at an impressive 2.1% CAGR to reach $112.2 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Bone Morphogenetic Proteins Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Bone Morphogenetic Proteins Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Bone Morphogenetic Proteins Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Cellumed Co. Ltd, DePuy Synthes, Ember Therapeutics, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 53 Featured):
- Cellumed Co. Ltd
- DePuy Synthes
- Ember Therapeutics
- Medtronic
- Musculoskeletal Transplant Foundation
- Nuvasive, Inc
- Orthofix Holdings, Inc
- ProSpec-Tany TechnoGene Ltd
- Sigma-Aldrich Co
- Smith and Nephew, Inc
- Stryker Corporation
- Wright Medical Group N.V.
- Xtant Medical Holdings, Inc
- Zimmer Biomet Holdings, Inc
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Bone Morphogenetic Proteins - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Bone Morphogenetic Proteins by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Bone Morphogenetic Proteins by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Recombinant human bone morphogenetic protein-2 (rhBMP-2) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Recombinant human bone morphogenetic protein-2 (rhBMP-2) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Recombinant human bone morphogenetic protein-2 (rhBMP-2) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Recombinant human bone morphogenetic protein-7 (rhBMP-7) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Recombinant human bone morphogenetic protein-7 (rhBMP-7) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Recombinant human bone morphogenetic protein-7 (rhBMP-7) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 11: World Historic Review for Spinal Fusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 12: World 16-Year Perspective for Spinal Fusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 14: World Historic Review for Trauma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 15: World 16-Year Perspective for Trauma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 17: World Historic Review for Reconstructive Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 18: World 16-Year Perspective for Reconstructive Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Oral-Maxillofacial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 20: World Historic Review for Oral-Maxillofacial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 21: World 16-Year Perspective for Oral-Maxillofacial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 22: World Bone Morphogenetic Proteins Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
UNITED STATES
- Bone Morphogenetic Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 23: USA Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 24: USA Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 25: USA 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 27: USA Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 28: USA 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
CANADA
- Table 29: Canada Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 30: Canada Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 31: Canada 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 32: Canada Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 33: Canada Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 34: Canada 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
JAPAN
- Bone Morphogenetic Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 35: Japan Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 36: Japan Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 37: Japan 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 38: Japan Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 39: Japan Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 40: Japan 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
CHINA
- Bone Morphogenetic Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 41: China Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 42: China Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 43: China 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 44: China Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 45: China Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 46: China 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
EUROPE
- Bone Morphogenetic Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 47: Europe Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- Table 48: Europe Historic Review for Bone Morphogenetic Proteins by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 49: Europe 16-Year Perspective for Bone Morphogenetic Proteins by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 50: Europe Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 51: Europe Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 52: Europe 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 53: Europe Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 54: Europe Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 55: Europe 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
FRANCE
- Bone Morphogenetic Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 56: France Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 57: France Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 58: France 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 59: France Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 60: France Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 61: France 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
GERMANY
- Bone Morphogenetic Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 62: Germany Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 63: Germany Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 64: Germany 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 65: Germany Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 66: Germany Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 67: Germany 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
ITALY
- Table 68: Italy Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 69: Italy Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 70: Italy 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 71: Italy Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 72: Italy Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 73: Italy 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Bone Morphogenetic Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 74: UK Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 75: UK Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 76: UK 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 77: UK Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 78: UK Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 79: UK 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 80: Rest of Europe Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 81: Rest of Europe Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 82: Rest of Europe 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 83: Rest of Europe Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 84: Rest of Europe Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 85: Rest of Europe 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Bone Morphogenetic Proteins Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 87: Asia-Pacific Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 88: Asia-Pacific 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 90: Asia-Pacific Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 91: Asia-Pacific 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
REST OF WORLD
- Table 92: Rest of World Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 93: Rest of World Historic Review for Bone Morphogenetic Proteins by Type - Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 94: Rest of World 16-Year Perspective for Bone Morphogenetic Proteins by Type - Percentage Breakdown of Value Sales for Recombinant human bone morphogenetic protein-2 (rhBMP-2) and Recombinant human bone morphogenetic protein-7 (rhBMP-7) for the Years 2014, 2024 & 2030
- Table 95: Rest of World Recent Past, Current & Future Analysis for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- Table 96: Rest of World Historic Review for Bone Morphogenetic Proteins by Application - Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- Table 97: Rest of World 16-Year Perspective for Bone Morphogenetic Proteins by Application - Percentage Breakdown of Value Sales for Spinal Fusion, Trauma, Reconstructive Surgery and Oral-Maxillofacial for the Years 2014, 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cellumed Co. Ltd
- DePuy Synthes
- Ember Therapeutics
- Medtronic
- Musculoskeletal Transplant Foundation
- Nuvasive, Inc
- Orthofix Holdings, Inc
- ProSpec-Tany TechnoGene Ltd
- Sigma-Aldrich Co
- Smith and Nephew, Inc
- Stryker Corporation
- Wright Medical Group N.V.
- Xtant Medical Holdings, Inc
- Zimmer Biomet Holdings, Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 202 |
| Published | October 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 545.3 Million |
| Forecasted Market Value ( USD | $ 643 Million |
| Compound Annual Growth Rate | 2.4% |
| Regions Covered | Global |
